Name
PD13-01 - Balixafortide ( CXCR4 Antagonist) +Eribulin Versus Eribulin Alone in Patients with HER2 Negative, Locally Recurrent or Metastatic Breast Cancer: An International, Randomized, Phase 3 Trial (FORTRESS)
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link